Best Buy Other Non-Current Liabilities decreased by 3.6% to $509.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.7%, from $523.00M to $509.00M. Over 5 years (FY 2021 to FY 2026), Other Non-Current Liabilities shows a downward trend with a -5.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $694.00M | $554.00M | $553.00M | $533.00M | $558.00M | $472.00M | $500.00M | $705.00M | $704.00M | $651.00M | $660.00M | $654.00M | $665.00M | $593.00M | $551.00M | $532.00M | $523.00M | $528.00M | $556.00M | $528.00M | $509.00M |
| QoQ Change | — | -20.2% | -0.2% | -3.6% | +4.7% | -15.4% | +5.9% | +41.0% | -0.1% | -7.5% | +1.4% | -0.9% | +1.7% | -10.8% | -7.1% | -3.4% | -1.7% | +1.0% | +5.3% | -5.0% | -3.6% |
| YoY Change | — | — | — | — | -19.6% | -14.8% | -9.6% | +32.3% | +26.2% | +37.9% | +32.0% | -7.2% | -5.5% | -8.9% | -16.5% | -18.7% | -21.4% | -11.0% | +0.9% | -0.8% | -2.7% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|
| Long-term liabilities | $239.00M | $233.00M | $237.00M | $229.00M |
| Total | $665.00M | $593.00M | $551.00M | $532.00M |